Skip to main content
  • Home

Recent Posts by our contributor, jessica davids

Johnson & Johnson's type 2 diabetes drug trumps Januvia
Mon, 06/11/2012 - 3:53pm

According to data from five late stage clinical studies, Johnson & Johnson’s new anti-diabetic drug canagliflozin decreased blood sugar by a significant amount when compared to alternative trea

Statins may make you sleepy
Tue, 06/12/2012 - 3:11pm

A recent randomized study revealed general fatigue and lack of energy during exercise as possible adverse side effects of statins in patients looking to reduce cholesterol.
 

Diabetes Drug Could Increase Risk of Blindness
Thu, 06/14/2012 - 10:56am

A large-scale study uncovered greater possible risk of diabetic macular edema in patients taking thiazolidinediones like pioglitazone (

Actos' role in blindness and bladder cancer
Thu, 06/14/2012 - 3:11pm

Recent studies reveal that thiazolidinediones like pioglitazone (Actos) and rosiglitazone (Avandia) pose both an increased

FDA OKs new meningitis vaccine for babies
Fri, 06/15/2012 - 3:16pm

The U.S.

Follow us:
  • facebook
  • twitter
  • YouTube

 

  • Popular
  • Recent
  • Tags
  • Alzheimer's drug disappoints

    • Aug 8, 2012
  • FDA, companies to study metal-on-metal implant effects

    • Jul 2, 2012
  • Johnson & Johnson could learn a thing or two from Smith & Nephew

    • Jun 6, 2012
  • Canadian study shows Actos doubles bladder cancer risk

    • Jun 8, 2012
  • Warfarin alternatives create concerns

    • Jun 22, 2012
  • Medicaid patients sue D.C. over drug denials

    • Jul 9, 2012
  • FDA issues warning after codeine kills children post-surgery

    • Aug 16, 2012
  • Artificial retina gives sight to blind mice

    • Aug 16, 2012
  • Lucentis approved for diabetic macular edema

    • Aug 14, 2012
  • Mayo Clinic: Patients in the dark about prescriptions

    • Aug 9, 2012
  • Hospital's plan to prevent painkiller abuse

    • Aug 8, 2012
  • Alzheimer's drug disappoints

    • Aug 8, 2012
settlement Nature Nexavar diet drug medical malpractice stroke colon cancer yo GlaxoSmithKline pulomonary embolism listeria meningitis HIV test EMA Roche type 2 diabetes diet pill lorcaserin Tempah breast cancer Tutorials D.C. statin Actos coumadin generic regorafenib Warfarin Fen-Phen Lexapro

More Dangerous Drug News

Lipitor Type 2 Diabetes Lawsuit

Get News Updates By Email

@ConsumerDrugRep Tweets

Archives

  • June 2011 (3)
  • September 2011 (1)
  • October 2011 (3)
  • November 2011 (5)
  • December 2011 (25)
  • January 2012 (8)
  • February 2012 (24)
  • March 2012 (20)
  • April 2012 (6)
  • May 2012 (12)

Pages

  • 1
  • 2
  • next ›
  • last »
Thursday, 26 May 2022
  • Subscribe by RSS
Consumer Drug Report
  • Tylenol
  • Miscellaneous
    • Avaira
  • Antidepressants
  • Fosamax
  • Pradaxa
  • Actos
  • Yaz
About Us

From side effects to recalls to pending lawsuits, Consumer Drug Report keeps you up to date with the latest information on pharmaceutical safety.

To submit questions or story ideas, please post on our Consumer Drug Report Facebook page,

tweet at us @ConsumerDrugRep, or

email us at news@consumer-drug-report.com.

Details

Home

About

Contact

Privacy

Sitemap 

Disclaimer

Categories
  • Actos
  • Antidepressants
  • Avaira
  • Fosamax
  • Miscellaneous
  • Pradaxa
  • Tylenol
  • Yaz

Brought to you by Spangenberg Shibley & Liber, LLP © 2012